| Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial M Azizi, RE Schmieder, F Mahfoud, MA Weber, J Daemen, J Davies, ... The Lancet 391 (10137), 2335-2345, 2018 | 657 | 2018 |
| Reduction of sympathetic hyperactivity by enalapril in patients with chronic renal failure G Ligtenberg, PJ Blankestijn, PL Oey, IHH Klein, LT Dijkhorst-Oei, ... New England Journal of Medicine 340 (17), 1321-1328, 1999 | 648 | 1999 |
| Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes MPC Grooteman, MA van den Dorpel, ML Bots, EL Penne, ... Journal of the American Society of Nephrology 23 (6), 1087-1096, 2012 | 611 | 2012 |
| Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis BK Mahmoodi, K Matsushita, M Woodward, PJ Blankestijn, M Cirillo, ... The Lancet 380 (9854), 1649-1661, 2012 | 563 | 2012 |
| Sympathetic activation markedly reduces endothelium-dependent, flow-mediated vasodilation ML Hijmering, ESG Stroes, J Olijhoek, BA Hutten, PJ Blankestijn, ... Journal of the American College of Cardiology 39 (4), 683-688, 2002 | 471 | 2002 |
| Hemodialysis arteriovenous fistula patency revisited: results of a prospective, multicenter initiative HJT Huijbregts, ML Bots, CHA Wittens, YC Schrama, FL Moll, ... Clinical journal of the American Society of Nephrology 3 (3), 714-719, 2008 | 429 | 2008 |
| Sympathetic hyperactivity in chronic renal failure: a wake-up call HA Koomans, PJ Blankestijn, JA Joles Journal of the American Society of Nephrology 15 (3), 524-537, 2004 | 399 | 2004 |
| Sympathetic hyperactivity in chronic kidney disease: pathogenesis, clinical relevance, and treatment J Neumann, G Ligtenberg, II Klein, HA Koomans, PJ Blankestijn Kidney international 65 (5), 1568-1576, 2004 | 388 | 2004 |
| Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CT Chan, PJ Blankestijn, LM Dember, M Gallieni, DCH Harris, CE Lok, ... Kidney international 96 (1), 37-47, 2019 | 324 | 2019 |
| Sympathetic activity is increased in polycystic kidney disease and is associated with hypertension IHHT Klein, G Ligtenberg, PL Oey, HA Koomans, PJ Blankestijn Journal of the American Society of Nephrology 12 (11), 2427-2433, 2001 | 313 | 2001 |
| Online haemodiafiltration: definition, dose quantification and safety revisited JE Tattersall, RA Ward, EUDIAL group, B Canaud, PJ Blankestijn, M Bots, ... Nephrology Dialysis Transplantation 28 (3), 542-550, 2013 | 303 | 2013 |
| Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients P Willeit, L Tschiderer, E Allara, K Reuber, L Seekircher, LU Gao, X Liao, ... Circulation 142 (7), 621-642, 2020 | 286 | 2020 |
| Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials HJL Heerspink, T Greene, H Tighiouart, RT Gansevoort, J Coresh, ... The lancet Diabetes & endocrinology 7 (2), 128-139, 2019 | 267 | 2019 |
| Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials SAE Peters, ML Bots, B Canaud, A Davenport, MPC Grooteman, F Kircelli, ... Nephrology Dialysis Transplantation 31 (6), 978-984, 2016 | 266 | 2016 |
| Chronic kidney disease and arrhythmias: conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference MP Turakhia, PJ Blankestijn, JJ Carrero, CM Clase, R Deo, CA Herzog, ... European heart journal 39 (24), 2314-2325, 2018 | 259 | 2018 |
| Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies J Coresh, HJL Heerspink, Y Sang, K Matsushita, J Arnlov, BC Astor, ... The lancet Diabetes & endocrinology 7 (2), 115-127, 2019 | 255 | 2019 |
| Sympathetic nerve activity is inappropriately increased in chronic renal disease IHHT Klein, G Ligtenberg, J Neumann, PL Oey, HA Koomans, ... Journal of the American Society of Nephrology 14 (12), 3239-3244, 2003 | 232 | 2003 |
| Cardiovascular Risk Factors in Renal Transplant Patients: Cyclosporin A: Versus: Tacrolimus G Ligtenberg, RJ Hené, PJ Blankestijn, HA Koomans Journal of the American Society of Nephrology 12 (2), 368-373, 2001 | 227 | 2001 |
| Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial M Azizi, K Sanghvi, M Saxena, P Gosse, JP Reilly, T Levy, LC Rump, ... The Lancet 397 (10293), 2476-2486, 2021 | 221 | 2021 |
| International expert consensus statement: percutaneous transluminal renal denervation for the treatment of resistant hypertension MP Schlaich, RE Schmieder, G Bakris, PJ Blankestijn, M Böhm, ... Journal of the American College of Cardiology 62 (22), 2031-2045, 2013 | 213 | 2013 |
